Phentolamine - Repros Therapeutics
Alternative Names: Vasofem; Vasomax; Z-MAXLatest Information Update: 25 Sep 2021
At a glance
- Originator Repros Therapeutics
- Developer Industria Quimica e Farmaceutica Schering-Plough; Repros Therapeutics
- Class Antiglaucomas; Erectile dysfunction therapies; Eye disorder therapies; Imidazoles; Peripheral vasodilators; Small molecules
- Mechanism of Action Alpha adrenergic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- Available For Licensing Yes
Highest Development Phases
- Marketed Erectile dysfunction
- Discontinued Female sexual dysfunction
Most Recent Events
- 03 Nov 2003 Discontinued - Phase-I for Female sexual dysfunction in USA (PO)
- 03 Nov 2003 Discontinued - Phase-I for Female sexual dysfunction in USA (Vaginal)
- 03 Nov 2003 Discontinued - Preregistration for Erectile dysfunction in USA (PO)